AML-454 Real-World Use of Azacitidine (AZA) and Venetoclax (VEN) in Acute Myeloid Leukemia (AML) in Frontline and Relapse/Refractory (R/R) Settings: Multicenter Study From French AURAML Group

Autor: Heiblig, Maël, Tavernier, Emmanuelle, Requena, Gaspar Aspas, Belhabri, Amine, Mauz, Natacha, Contejean, Adrien, Pica, Gian-Matteo, Carré, Martin, Rocher, Clément, Santana, Clémence, Gross, Zofia
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S303-S303
Databáze: ScienceDirect
Externí odkaz: